View in EDS

Reprogramming glutamine metabolism enhances BCMA-CAR T-cell fitness and therapeutic efficacy in multiple myeloma.

Saved in:
Bibliographic Details
Title: Reprogramming glutamine metabolism enhances BCMA-CAR T-cell fitness and therapeutic efficacy in multiple myeloma.
Authors: Navarro F; Immunology and Immunotherapy Program, Center for Applied Medical Research, Cancer Center University of Navarra, Navarra Institute for Health Research, CIBERONC, Pamplona, Spain., Lozano T; Immunology and Immunotherapy Program, Center for Applied Medical Research, Cancer Center University of Navarra, Navarra Institute for Health Research, CIBERONC, Pamplona, Spain., Fuentes-García A; Immunology and Immunotherapy Program, Center for Applied Medical Research, Cancer Center University of Navarra, Navarra Institute for Health Research, CIBERONC, Pamplona, Spain., Sánchez-Moreno I; Immunology and Immunotherapy Program, Center for Applied Medical Research, Cancer Center University of Navarra, Navarra Institute for Health Research, CIBERONC, Pamplona, Spain., Larrayoz M; Hemato-Oncology Program, Center for Applied Medical Research, Cancer Center University of Navarra, Navarra Institute for Health Research, CIBERONC, Pamplona, Spain., Justicia P; Immunology and Immunotherapy Program, Center for Applied Medical Research, Cancer Center University of Navarra, Navarra Institute for Health Research, CIBERONC, Pamplona, Spain., Perucha B; Immunology and Immunotherapy Program, Center for Applied Medical Research, Cancer Center University of Navarra, Navarra Institute for Health Research, CIBERONC, Pamplona, Spain., Martinez-Tabar M; Immunology and Immunotherapy Program, Center for Applied Medical Research, Cancer Center University of Navarra, Navarra Institute for Health Research, CIBERONC, Pamplona, Spain., Martinez-Turrillas R; Hemato-Oncology Program, Center for Applied Medical Research, Cancer Center University of Navarra, Navarra Institute for Health Research, CIBERONC, Pamplona, Spain., Casares N; Immunology and Immunotherapy Program, Center for Applied Medical Research, Cancer Center University of Navarra, Navarra Institute for Health Research, CIBERONC, Pamplona, Spain., Martín-Otal C; Immunology and Immunotherapy Program, Center for Applied Medical Research, Cancer Center University of Navarra, Navarra Institute for Health Research, CIBERONC, Pamplona, Spain., Gorraiz M; Immunology and Immunotherapy Program, Center for Applied Medical Research, Cancer Center University of Navarra, Navarra Institute for Health Research, CIBERONC, Pamplona, Spain., Meermeier EW; Department of Immunology, Mayo Clinic, Scottsdale, AZ., Chesi M; Division of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ., Lake D; School of Life Sciences, Arizona State University, Phoenix, AZ., Bergsagel PL; Division of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ., Santamaría E; RNA Biology and Therapy Program, Center for Applied Medical Research, Cancer Center University of Navarra, University of Navarra, Pamplona, Spain.; CIBERehd, Madrid, Spain., Calleja-Cervantes ME; Hemato-Oncology Program, Center for Applied Medical Research, Cancer Center University of Navarra, Navarra Institute for Health Research, CIBERONC, Pamplona, Spain., San Martín-Uriz P; Hemato-Oncology Program, Center for Applied Medical Research, Cancer Center University of Navarra, Navarra Institute for Health Research, CIBERONC, Pamplona, Spain., Jordana-Urriza L; Hemato-Oncology Program, Center for Applied Medical Research, Cancer Center University of Navarra, Navarra Institute for Health Research, CIBERONC, Pamplona, Spain., Agirre X; Hemato-Oncology Program, Center for Applied Medical Research, Cancer Center University of Navarra, Navarra Institute for Health Research, CIBERONC, Pamplona, Spain., Hervás-Stubbs S; Immunology and Immunotherapy Program, Center for Applied Medical Research, Cancer Center University of Navarra, Navarra Institute for Health Research, CIBERONC, Pamplona, Spain., Rodriguez-Madoz JR; Hemato-Oncology Program, Center for Applied Medical Research, Cancer Center University of Navarra, Navarra Institute for Health Research, CIBERONC, Pamplona, Spain., Martinez-Climent JÁ; Hemato-Oncology Program, Center for Applied Medical Research, Cancer Center University of Navarra, Navarra Institute for Health Research, CIBERONC, Pamplona, Spain., Prosper F; Hemato-Oncology Program, Center for Applied Medical Research, Cancer Center University of Navarra, Navarra Institute for Health Research, CIBERONC, Pamplona, Spain.; Hematology and Cell Therapy Department, Clínica Universidad de Navarra, Pamplona, Spain., Lasarte JJ; Immunology and Immunotherapy Program, Center for Applied Medical Research, Cancer Center University of Navarra, Navarra Institute for Health Research, CIBERONC, Pamplona, Spain.
Source: Blood [Blood] 2025 Dec 11; Vol. 146 (24), pp. 2931-2944.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40971494
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Reprogramming glutamine metabolism enhances BCMA-CAR T-cell fitness and therapeutic efficacy in multiple myeloma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Navarro+F%22">Navarro F</searchLink>; Immunology and Immunotherapy Program, Center for Applied Medical Research, Cancer Center University of Navarra, Navarra Institute for Health Research, CIBERONC, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Lozano+T%22">Lozano T</searchLink>; Immunology and Immunotherapy Program, Center for Applied Medical Research, Cancer Center University of Navarra, Navarra Institute for Health Research, CIBERONC, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Fuentes-García+A%22">Fuentes-García A</searchLink>; Immunology and Immunotherapy Program, Center for Applied Medical Research, Cancer Center University of Navarra, Navarra Institute for Health Research, CIBERONC, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Sánchez-Moreno+I%22">Sánchez-Moreno I</searchLink>; Immunology and Immunotherapy Program, Center for Applied Medical Research, Cancer Center University of Navarra, Navarra Institute for Health Research, CIBERONC, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Larrayoz+M%22">Larrayoz M</searchLink>; Hemato-Oncology Program, Center for Applied Medical Research, Cancer Center University of Navarra, Navarra Institute for Health Research, CIBERONC, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Justicia+P%22">Justicia P</searchLink>; Immunology and Immunotherapy Program, Center for Applied Medical Research, Cancer Center University of Navarra, Navarra Institute for Health Research, CIBERONC, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Perucha+B%22">Perucha B</searchLink>; Immunology and Immunotherapy Program, Center for Applied Medical Research, Cancer Center University of Navarra, Navarra Institute for Health Research, CIBERONC, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Martinez-Tabar+M%22">Martinez-Tabar M</searchLink>; Immunology and Immunotherapy Program, Center for Applied Medical Research, Cancer Center University of Navarra, Navarra Institute for Health Research, CIBERONC, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Martinez-Turrillas+R%22">Martinez-Turrillas R</searchLink>; Hemato-Oncology Program, Center for Applied Medical Research, Cancer Center University of Navarra, Navarra Institute for Health Research, CIBERONC, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Casares+N%22">Casares N</searchLink>; Immunology and Immunotherapy Program, Center for Applied Medical Research, Cancer Center University of Navarra, Navarra Institute for Health Research, CIBERONC, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Martín-Otal+C%22">Martín-Otal C</searchLink>; Immunology and Immunotherapy Program, Center for Applied Medical Research, Cancer Center University of Navarra, Navarra Institute for Health Research, CIBERONC, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Gorraiz+M%22">Gorraiz M</searchLink>; Immunology and Immunotherapy Program, Center for Applied Medical Research, Cancer Center University of Navarra, Navarra Institute for Health Research, CIBERONC, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Meermeier+EW%22">Meermeier EW</searchLink>; Department of Immunology, Mayo Clinic, Scottsdale, AZ.<br /><searchLink fieldCode="AU" term="%22Chesi+M%22">Chesi M</searchLink>; Division of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ.<br /><searchLink fieldCode="AU" term="%22Lake+D%22">Lake D</searchLink>; School of Life Sciences, Arizona State University, Phoenix, AZ.<br /><searchLink fieldCode="AU" term="%22Bergsagel+PL%22">Bergsagel PL</searchLink>; Division of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ.<br /><searchLink fieldCode="AU" term="%22Santamaría+E%22">Santamaría E</searchLink>; RNA Biology and Therapy Program, Center for Applied Medical Research, Cancer Center University of Navarra, University of Navarra, Pamplona, Spain.; CIBERehd, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Calleja-Cervantes+ME%22">Calleja-Cervantes ME</searchLink>; Hemato-Oncology Program, Center for Applied Medical Research, Cancer Center University of Navarra, Navarra Institute for Health Research, CIBERONC, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22San+Martín-Uriz+P%22">San Martín-Uriz P</searchLink>; Hemato-Oncology Program, Center for Applied Medical Research, Cancer Center University of Navarra, Navarra Institute for Health Research, CIBERONC, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Jordana-Urriza+L%22">Jordana-Urriza L</searchLink>; Hemato-Oncology Program, Center for Applied Medical Research, Cancer Center University of Navarra, Navarra Institute for Health Research, CIBERONC, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Agirre+X%22">Agirre X</searchLink>; Hemato-Oncology Program, Center for Applied Medical Research, Cancer Center University of Navarra, Navarra Institute for Health Research, CIBERONC, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Hervás-Stubbs+S%22">Hervás-Stubbs S</searchLink>; Immunology and Immunotherapy Program, Center for Applied Medical Research, Cancer Center University of Navarra, Navarra Institute for Health Research, CIBERONC, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Rodriguez-Madoz+JR%22">Rodriguez-Madoz JR</searchLink>; Hemato-Oncology Program, Center for Applied Medical Research, Cancer Center University of Navarra, Navarra Institute for Health Research, CIBERONC, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Martinez-Climent+JÁ%22">Martinez-Climent JÁ</searchLink>; Hemato-Oncology Program, Center for Applied Medical Research, Cancer Center University of Navarra, Navarra Institute for Health Research, CIBERONC, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Prosper+F%22">Prosper F</searchLink>; Hemato-Oncology Program, Center for Applied Medical Research, Cancer Center University of Navarra, Navarra Institute for Health Research, CIBERONC, Pamplona, Spain.; Hematology and Cell Therapy Department, Clínica Universidad de Navarra, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Lasarte+JJ%22">Lasarte JJ</searchLink>; Immunology and Immunotherapy Program, Center for Applied Medical Research, Cancer Center University of Navarra, Navarra Institute for Health Research, CIBERONC, Pamplona, Spain.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227603509%22">Blood</searchLink> [Blood] 2025 Dec 11; Vol. 146 (24), pp. 2931-2944.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7603509 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1528-0020 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200064971%22">00064971 </searchLink><i>NLM ISO Abbreviation: </i>Blood <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40971494
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1182/blood.2024027496
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2931
    Titles:
      – TitleFull: Reprogramming glutamine metabolism enhances BCMA-CAR T-cell fitness and therapeutic efficacy in multiple myeloma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Navarro F
      – PersonEntity:
          Name:
            NameFull: Lozano T
      – PersonEntity:
          Name:
            NameFull: Fuentes-García A
      – PersonEntity:
          Name:
            NameFull: Sánchez-Moreno I
      – PersonEntity:
          Name:
            NameFull: Larrayoz M
      – PersonEntity:
          Name:
            NameFull: Justicia P
      – PersonEntity:
          Name:
            NameFull: Perucha B
      – PersonEntity:
          Name:
            NameFull: Martinez-Tabar M
      – PersonEntity:
          Name:
            NameFull: Martinez-Turrillas R
      – PersonEntity:
          Name:
            NameFull: Casares N
      – PersonEntity:
          Name:
            NameFull: Martín-Otal C
      – PersonEntity:
          Name:
            NameFull: Gorraiz M
      – PersonEntity:
          Name:
            NameFull: Meermeier EW
      – PersonEntity:
          Name:
            NameFull: Chesi M
      – PersonEntity:
          Name:
            NameFull: Lake D
      – PersonEntity:
          Name:
            NameFull: Bergsagel PL
      – PersonEntity:
          Name:
            NameFull: Santamaría E
      – PersonEntity:
          Name:
            NameFull: Calleja-Cervantes ME
      – PersonEntity:
          Name:
            NameFull: San Martín-Uriz P
      – PersonEntity:
          Name:
            NameFull: Jordana-Urriza L
      – PersonEntity:
          Name:
            NameFull: Agirre X
      – PersonEntity:
          Name:
            NameFull: Hervás-Stubbs S
      – PersonEntity:
          Name:
            NameFull: Rodriguez-Madoz JR
      – PersonEntity:
          Name:
            NameFull: Martinez-Climent JÁ
      – PersonEntity:
          Name:
            NameFull: Prosper F
      – PersonEntity:
          Name:
            NameFull: Lasarte JJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 11
              M: 12
              Text: 2025 Dec 11
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1528-0020
          Numbering:
            – Type: volume
              Value: 146
            – Type: issue
              Value: 24
          Titles:
            – TitleFull: Blood
              Type: main
ResultId 1